Category Archives: DSM-5

Changes to ICD-10 Mental Health Codes October 1st

The mental health chapter of the International Classification of Diseases, Tenth Edition, Clinical Modification (ICD-10) will take effect October 1 and reflect the updated diagnoses in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Each year on … Continue reading

Posted in Diagnosis, DSM-5, ICD-10 | Comments Off on Changes to ICD-10 Mental Health Codes October 1st

Atypical Antipsychotic Shows Promise for New MDD Subtype

New to the diagnosis of major depressive disorder as of DSM-5 is the specifier “with mixed features.” According to DSM-5, “specifiers provide an opportunity to define a more homogeneous subgrouping of individuals with the disorder who share certain features (e.g., … Continue reading

Posted in Antipsychotic medication, Depression, Diagnosis, DSM-5, mixed features, Treatment | Comments Off on Atypical Antipsychotic Shows Promise for New MDD Subtype

Assessment of Global Internet Addiction

According to a meta-analysis of 31 nations across seven world regions, the global prevalence of internet addiction is estimated at 6 percent. The prevalence of Internet addiction varies among regions around the world, as shown by data from more than … Continue reading

Posted in Addiction, Diagnosis, DSM-5, Internet, Internet Addiction | Comments Off on Assessment of Global Internet Addiction

Comparison of DSM-IV Versus DSM-5 ADHD Criteria Supports Revision

A study published in the Journal of the American Academy of Child and Adolescent Psychiatry compares ADHD diagnosed via the DSM-IV criteria and the new DSM-5 in youth.  Researchers from the National Institute of Mental Health compared the prevalence and clinical correlates … Continue reading

Posted in ADHD, DSM-5 | Comments Off on Comparison of DSM-IV Versus DSM-5 ADHD Criteria Supports Revision

Sixth Annual Chair Summit Begins This Week

This week a Master Class for Neuroscience Development called the Chair Summit takes place in Tampa, FL (Sept 26-28, 2013). In the early days of medical training in Kos, students, trainees and medical colleagues would gather to discuss their cases … Continue reading

Posted in Addiction, ADHD, Antipsychotic medication, Anxiety Disorders, Biomarker, Bipolar Disorder, Cardiovascular Risk Factors, Chronic Pain, CME, Dementia, Depression, Diabetes, Diagnosis, Digital medicine, Drug Development, Drugs, DSM-5, Early intervention, Education, Food, Genetics, Guideline, Imaging, Maintenance of Certification, Measurement-based care, Medical Education, Mood, MRI, Multiple sclerosis, Negative symptoms, Neuroscience, Obesity, Opioids, PET, Practice guideline, Psychosis, PTSD, Research, Schizophrenia, Smoking cessation, Social media, Stroke, Substance abuse, Transcranial magnetic stimulation, Vascular dementia | Comments Off on Sixth Annual Chair Summit Begins This Week

David Kupfer, MD Responds to NIMH Criticism of DSM-5

David Kupfer, M.D, chair of APA’s DSM-5 Task Force responds to recent criticism of DSM-5 and its previous iterations by NIMH Director Thomas Insel, M.D. In a statement issued, Dr Kupfer emphasized that the diagnostic manual “provides clinicians with a … Continue reading

Posted in Diagnosis, DSM-5 | Comments Off on David Kupfer, MD Responds to NIMH Criticism of DSM-5

National Institute on Mental Health Abandons DSM-5

Two weeks before DSM-5 goes on sale, Thomas Insel,  Director of the National Institute on Mental Health (NIMH) writes that the DSM lacks validity and that “patients with mental disorders deserve better”. According to Dr Insel, “The goal of this … Continue reading

Posted in Diagnosis, DSM-5, NIMH, Research | Comments Off on National Institute on Mental Health Abandons DSM-5